Progress Toward the Synthesis of a Next-Generation Tyrosine Kinase Inhibitor

被引：0
|
作者：
Budd, Madeline [1 ]
Brenz, Mariah [1 ]
Hirschfield, Theodore [1 ]
Streu, Craig [1 ]
机构：
[1] Albion Coll, Albion, MI USA
来源：
JOURNAL OF BIOLOGICAL CHEMISTRY | 2023年 / 299卷 / 03期
关键词：
D O I：
10.1016/j.jbc.2023.103196
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
1272
引用
收藏
页码：S68 / S68
页数：1
相关论文
共 50 条
  • [1] Afatinib: emerging next-generation tyrosine kinase inhibitor for NSCLC
    Nelson, Valerie
    Ziehr, Jacqueline
    Agulnik, Mark
    Johnson, Melissa
    [J]. ONCOTARGETS AND THERAPY, 2013, 6 : 135 - 143
  • [2] Next-Generation Bruton Tyrosine Kinase Inhibitors
    Stephens, Deborah M.
    Byrd, John C.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (25) : 2937 - +
  • [3] Arrhythmogenic Ventricular Remodeling by Next-Generation Bruton's Tyrosine Kinase Inhibitor Acalabrutinib
    Zhao, Yanan
    Chakraborty, Praloy
    Tomassetti, Julianna
    Subha, Tasnia
    Masse, Stephane
    Thavendiranathan, Paaladinesh
    Billia, Filio
    Lai, Patrick F. H.
    Abdel-Qadir, Husam
    Nanthakumar, Kumaraswamy
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (11)
  • [4] Next Generation Tyrosine Kinase Inhibitor (TKI): Afatinib
    Kumar, Suresh
    Agrawal, Ritesh
    [J]. RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY, 2014, 9 (03) : 382 - 393
  • [5] Progress Toward the Synthesis of a Photoswitchable Kinase Inhibitor
    Rollison, Noah
    Rollison, Noah
    Kernen, Diana
    Reddy, Sathwik
    Streu, Craig
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2023, 299 (03) : S69 - S69
  • [6] Suppression of Bruton tyrosine kinase with X-022, a highly selective next-generation irreversible inhibitor
    Mulvihill, Mark J.
    Chen, Xiangyang
    Shaw, J. P.
    Liu, Richard
    Ni, Haihong
    Babiss, Lee
    Renzetti, Louis
    [J]. CANCER RESEARCH, 2014, 74 (19)
  • [7] Progress in tyrosine kinase inhibitor
    Peng, T
    Zhou, JJ
    [J]. PROGRESS IN CHEMISTRY, 2002, 14 (05) : 355 - 359
  • [8] Incorporating acalabrutinib, a selective next-generation Bruton tyrosine kinase inhibitor, into clinical practice for the treatment of haematological malignancies
    Danilov, Alexey V.
    Persky, Daniel O.
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2021, 193 (01) : 15 - 25
  • [9] The Discovery and Development of SU14813, a Next-Generation Multitargeted Tyrosine Kinase Inhibitor for the Treatment of Human Malignancies
    Hu-Lowe, Dana
    Brega, Nicoletta
    Patyna, Shem
    [J]. MOLECULAR CANCER THERAPEUTICS, 2011, 10 (11) : 2015 - 2015
  • [10] SENSORS - TOWARD THE NEXT-GENERATION
    WEISS, J
    [J]. INTECH, 1993, 40 (09) : 57 - 60
12345